Granules surge post USFDA nod for Potassium Chloride tablets
Granules surge post USFDA nod for Potassium Chloride tablets

Granules surge post USFDA nod for Potassium Chloride tablets

Apurva Joshi Article rating: 3.5

US Food & Drug Administration (USFDA) has approved Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign subsidiary of Granules India Limited for Potassium Chloride Extended-Release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg).

Rupee strengthens against US Dollar by 14 paise
Rupee strengthens against US Dollar by 14 paise

Rupee strengthens against US Dollar by 14 paise

Apurva Joshi Article rating: 5.0

Indian rupee gained against US dollar on Thursday, followed by firm domestic equities tracking global peers that gained on the back of former US Vice President Biden's big win, central banks' rate cut and World Bank's $12 billion aid package.

Andhra Bank reacts positively on stake hike by GoI
Andhra Bank reacts positively on stake hike by GoI

Andhra Bank reacts positively on stake hike by GoI

Pratik Shastri Article rating: 3.9

In terms of stock returns, PSU banks have performed very poorly, despite a consistent capital infusion by the government. Set of 18 PSU banking stocks has declined as much as 49 per cent since January 2019 till date.

Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets
Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets

Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets

Apurva Joshi Article rating: 5.0

Alembic Pharmaceuticals Limited has received final approval from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Doxycycline Hyclate Tablets USP, 20 mg.

Deepak Nitrite invests 20 per cent stake in DOIL
Deepak Nitrite invests 20 per cent stake in DOIL

Deepak Nitrite invests 20 per cent stake in DOIL

Apurva Joshi Article rating: 4.1

Deepak Nitrite Limited has informed the bourses about investing around 20 per cent stake in Deepak Oman Industries FZC LLC (DOIL), a Limited Liability Company (LLC) incorporated in Sultanate of Oman amounting to an investment of approximately USD 7.71 million, in one or more tranches.

Allcargo surges post SEBI nod to acquire stake in Gati
Allcargo surges post SEBI nod to acquire stake in Gati

Allcargo surges post SEBI nod to acquire stake in Gati

Amir Shaikh Article rating: 4.2

Allcargo Logistics on Wednesday informed the bourses that it has received the approval from SEBI on its open offer to acquire additional nearly 3.17 crore shares in Gati 

YES Bank rockets high up on confirmation by government
YES Bank rockets high up on confirmation by government

YES Bank rockets high up on confirmation by government

Geyatee Deshpande Article rating: 3.3

As part of the efforts to bail out the private lender, the government has approved a plan for State Bank of India (SBI) to lead a consortium that will buy a stake in YES Bank. The public-sector bank has also been authorised to pick other members of the consortium.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 3.1

The market opened in the green on March 5, 2020, overall volumes in futures & options currently stand at 2.88 crore contracts with a turnover of Rs. 19,40,551.91 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.3

The market opened in the green on March 5, 2020, overall volumes in futures & options currently stand at 2.88 crore contracts with a turnover of Rs. 19,40,551.91 crore.

RSS
First28722873287428752877287928802881Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR